Journal of the National Cancer Institute
Men faced high fracture risk after prostate cancer drugs
Three-year fracture risk exceeded 25% without a recent fracture and 50% with one; it remained above 44% among men with prior fractures using bone-health medicines.Three-year fracture risk exceeded 25% without a recent fracture and 50% with one; it remained above 44% among men with prior fractures using bone-health medicines.
Cohort · 10,463 peopleBone fracture
Who was studied10,463 men with advanced prostate cancer
What changedThree-year fracture risk exceeded 25% in men without prior fracture and 50% in those with a prior fracture
The catchFindings concern Medicare-insured men with advanced prostate cancer, not earlier-stage disease